Search Results
Aug 11, 2026, 08:30 ET FibroBiologics Granted U.S. Patent Covering the Use of Fibroblasts to Enhance Survival and Function of Transplanted Insulin-Producing Islets
including those set forth under the caption "Risk Factors" and elsewhere in FibroBiologics' annual, quarterly and current reports (i.e., Form 10-K, Form 10-Q and Form 8-K) as filed or furnished with the SEC and any subsequent public filings. Copies are available on the SEC's website,
More news about: FibroBiologics, Inc.
Aug 11, 2026, 08:27 ET Jake Collective Partners with The Jed Foundation (JED) to Safeguard the Wellbeing of Students Who Perceive Themselves and their World Differently
represent an ever-growing number of K-12 and college-age students, schools have faced challenges implementing relevant support systems and interventions to promote mental health and prevent suicide among this population. "Too often, one-size-fits-all interventions at K-12 schools, colleges and universities
More news about: The Jed Foundation; Jake Collective
Aug 11, 2026, 08:27 ET H.I.G. Capital fait l'acquisition de Phoenix ME
[email protected]. Capital10 Grosvenor Street2nd FloorLondres W1K 4QBTél. : +44 (0) 207 318 5700
More news about: H.I.G. Capital, LLC
Aug 11, 2026, 08:12 ET Rocket One Accepted into Seagate Partner Program, Expanding AI Infrastructure and Enterprise Data Storage Ecosystem
are described in the Company's filings with the Securities and Exchange Commission ("SEC") including the Company's most recent Annual Report on Form 10-K and the Company's other filings made with the SEC. Although the Company believes that the expectations reflected in the forward-looking statements are
More news about: Rocket One Inc.
Aug 11, 2026, 08:03 ET Onkos Surgical® Announces 1,000th Personalized My3D® Patient-Specific Pelvic Implant Case
solutions for musculoskeletal oncology and complex orthopaedic conditions, today announced the completion of the 1,000th case utilizing its personalized, 510(k) cleared, My3D® patient-specific pelvic implant platform.
More news about: Onkos Surgical
Aug 11, 2026, 08:00 ET Cignition Selected by Louisiana Department of Education to Provide Access to High-Dosage Tutoring in K-12 Schools
Cignition, an award-winning provider of high-impact K-12 virtual tutoring, today announced the Louisiana Department of Education (DOE) has chosen it as an approved provider of high-dosage tutoring for the
More news about: Cignition
Aug 11, 2026, 08:00 ET Bracco Marks Major Global Milestone with U.S. FDA 510(k) Clearance and Health Canada Authorization for VueJect®, the First Dedicated Ultrasound Contrast Delivery System to Support Cardiology Imaging
that VueJect®, its first dedicated ultrasound contrast delivery system engineered to support cardiology imaging specifically, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and authorization from Health Canada. These regulatory milestones represent the first step
More news about: Bracco Group
Aug 11, 2026, 08:00 ET TurnOnGreen's Digital Power Corporation Transitions Military-Grade Power System to Full-Scale Production
specifications; and other risks detailed in the Company's filings with the U.S. Securities and Exchange Commission ("SEC"), including Forms 10-K, 10-Q and 8-K. These filings are available at
More news about: TurnOnGreen, Inc.
Aug 11, 2026, 08:00 ET Lincoln Unified School District 298 Deploys ZeroEyes AI Gun Detection and Intelligent Situational Awareness Technology
Situated in the rural community of Lincoln, the school district employs 85 faculty and staff and serves approximately 330 students from Pre-K through 12th grade across Lincoln, Barnard, Beverly, Shady Bend, Westfall, and surrounding areas. Its two campuses include a pre-school, daycare, elementary
More news about: ZeroEyes
Aug 11, 2026, 08:00 ET Bongards' Creameries Announces $135 Million Expansion of Process Cheese Facility in Bongards, Minnesota
country's largest foodservice operators, food manufacturers and foodservice distributors. The company's cheeses can be found in commercial restaurants, K-12 schools, retail delis and C-stores, among others. Corporate offices are based in Chanhassen, Minn., and the company's three production facilities are
More news about: BONGARDS' CREAMERIES
Aug 11, 2026, 08:00 ET Allergan Aesthetics Refreshes Allergan Partner Privileges® to Better Support Today's Modern Aesthetics Practices
technological and other factors that may affect AbbVie's operations is set forth in Item 1A, "Risk Factors," of AbbVie's 2025 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its Quarterly Reports on Form 10-Q and in other documents that AbbVie
More news about: AbbVie
Aug 11, 2026, 08:00 ET Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
other risks and uncertainties that affect the Company's business, including those described in the "Risk Factors" section of its Annual Report on Form 10-K, as well as discussions of potential risks, uncertainties, and other important factors in the Company's subsequent filings with the Securities and Exchange
More news about: Sentynl Therapeutics
Aug 11, 2026, 08:00 ET Dominari Year to Date Revenue Increases by 14% Over 2025
forth in the Company's filings with the SEC, which include but are not limited to the Risk Factors set forth in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, relating to its business. Thus, actual results could be materially different. The Company expressly
More news about: Dominari Holdings, Inc.
Aug 11, 2026, 07:55 ET Syra Health Achieves 23% Revenue Growth, Improves Gross Margin to 44.5% in Second Consecutive Profitable Quarter
expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2025, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained
More news about: Syra Health
Aug 11, 2026, 07:30 ET Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
requirements and needs for additional financing; and other risks described in the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2025 and in the Company's subsequent SEC filings, which can be obtained on the SEC website at
More news about: Intensity Therapeutics Inc.
Aug 11, 2026, 07:10 ET Sciton Marks Fourth Inc. 5000 Recognition, Reinforcing Its Leadership in Medical Aesthetics
Alto, California, is a forward-thinking, employee-owned medical device company founded in 1997 by industry visionaries James Hobart, PhD, and Daniel K. Negus, PhD. Renowned for delivering high-quality laser and light solutions, Sciton's product portfolio spans a broad range of medical and aesthetic applications,
More news about: Sciton
Aug 11, 2026, 07:01 ET CenterPoint Energy Announces Historic "Customer Savings Initiative" Projecting $5 Billion in Affordability Savings for Texas Electric Customers Over the Next Decade
legislative and political actions or developments; and (5) other factors, risks and uncertainties discussed in CenterPoint Energy's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and CenterPoint's Quarterly Report on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026 and
More news about: CenterPoint Energy, Inc
Aug 11, 2026, 07:00 ET Xtant Medical Reports Second Quarter 2026 Financial Results
access additional indebtedness or financing on favorable terms or at all, if and when needed; and other factors described in its Annual Report on Form 10-K for the year ended December 31, 2025 filed with the Securities and Exchange Commission (SEC) on March 30, 2026 and subsequent SEC reports, including its
More news about: Xtant Medical Holdings, Inc.
Aug 11, 2026, 06:50 ET Cardinal Infrastructure Group Inc. Reports Second Quarter 2026 Results and Updates 2026 Outlook, Announces Acquisition of Allied Paving
statements is subject to risks, uncertainties and other factors described in the section entitled "Risk Factors" in Cardinal's Annual Report on Form 10-K for the year ended December 31, 2025 (the "Annual Report"), and elsewhere in the Annual Report. Accordingly, you should not rely upon forward-looking
More news about: Cardinal Infrastructure Group Inc.
Aug 11, 2026, 06:45 ET Cardinal Health Reports Fourth Quarter and Fiscal Year 2026 Results and Provides Fiscal Year 2027 Guidance
components of our generics programs. Cardinal Health is subject to additional risks and uncertainties described in Cardinal Health's Form 10-K, Form 10-Q and Form 8K reports and exhibits to those reports. This release reflects management's views as of August 11, 2026. Except to the extent required by applicable
More news about: Cardinal Health, Inc.
Aug 11, 2026, 06:44 ET Online Language Learning Market to Grow at 15.8% by 2031 Driven by Rising Cross-Border Communication Demand, Says Mordor Intelligence
Mobile-first Uptake in Emerging Economies4.2.4 Corporate ESG and DEI Language-upskilling Mandates4.2.5 Early-age Language Mandates in K-12 Curricula4.2.6 Voice-assistant Ecosystem Skill Marketplaces4.3 Market Restraints4.3.1 Data-security and Privacy Concerns4.3.2
More news about: Mordor Intelligence Private Limited
Aug 11, 2026, 06:30 ET Hyperscale Data Board Considers All Options to Maximize Stockholder Value, Including Potential Sale of Its Michigan Data Center
results are included in the Company's filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company's Forms 10-K, 10-Q and 8-K. All filings are available at
More news about: Hyperscale Data Inc.
Aug 11, 2026, 06:30 ET Embecta Corp. Notice of August 17, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline
youtu.be/l64Fkc4K6q0Class Period: Nov. 25, 2025 – May 4, 2026Lead Plaintiff Deadline: Aug. 17, 2026Visit:
More news about: Hagens Berman Sobol Shapiro LLP
Aug 11, 2026, 06:30 ET Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update
descriptions of these risks, uncertainties and other factors can be found in the section captioned "Risk Factors," in the company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on February 26, 2026, and in the company's subsequent filings with the SEC. Copies of
More news about: Immunic, Inc.
Aug 11, 2026, 06:30 ET Keenova Reports Second Quarter 2026 Financial Results
Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2026, filed with the SEC,
More news about: Keenova Therapeutics